Carcinogenicity of formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]-hydrazide in Swiss mice.
D000230:Adenocarcinoma / Q000139:chemically induced / Q000473:pathology; D002282:Adenocarcinoma, Bronchiolo-Alveolar / Q000139:chemically induced / Q000473:pathology; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002273:Carcinogens / Q000008:administration & dosage; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced / Q000473:pathology; D004032:Diet; D005260:Female; D005561:Formates / Q000008:administration & dosage; D006834:Hydrazines / Q000008:administration & dosage; D007942:Leukemia, Experimental / Q000139:chemically induced / Q000473:pathology; D008113:Liver Neoplasms / Q000139:chemically induced / Q000473:pathology; D008175:Lung Neoplasms / Q000139:chemically induced; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000473:pathology; D051379:Mice; D009362:Neoplasm Metastasis; D009374:Neoplasms, Experimental / Q000139:chemically induced* / Q000473:pathology; D009581:Nitrofurans / Q000008:administration & dosage; D012878:Skin Neoplasms / Q000139:chemically induced / Q000473:pathology; D013274:Stomach Neoplasms / Q000139:chemically induced; D013844:Thiazoles / Q000008:administration & dosage; D014594:Uterine Neoplasms / Q000139:chemically induced / Q000473:pathology
D002273:Carcinogens; D005561:Formates; D006834:Hydrazines; D009581:Nitrofurans; D013844:Thiazoles